Clinical Trial Update: PK/PD Target Attainment of Ceftriaxone for the Prevention of Early Ventilator-associated Pneumonia in Neurologically Injured Patients

View source ↗

Summary

A planned clinical trial is evaluating PK/PD target attainment of ceftriaxone to prevent early ventilator-associated pneumonia in neurologically injured patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury
• Ventilator-associated Pneumonia

Drugs mentioned

• Rocephin (Ceftriaxone) (Ceftriaxone)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Early Ventilator Associated Pneumonia, Acute Brain Injuries | Status: NOT_YET_RECRUITING